St. Jude finds NLRP12 as a new drug target for infection, inflammation and hemolytic diseases
St. Jude Children's Research HospitalScientists at St. Jude Children’s Research Hospital found key “on” switch, NLRP12, for innate immune cell death in diseases that cause red blood cells to rupture, which can lead to inflammation and multi-organ failure.